VIJAYA DIAGNOSTIC CENTRE LIMITED Financials Vijaya Diagnostic Centre Limited
Equities
VIJAYA
INE043W01024
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 802.9 INR | +9.95% |
|
+17.83% | +18.82% |
Valuation
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 44,676 | 39,940 | 82,310 | - | - |
| Enterprise Value (EV) 1 | 44,676 | 38,922 | 65,153 | 80,336 | 79,236 |
| P/E ratio | 41 x | 47.4 x | 54.9 x | 54.1 x | 43.9 x |
| Yield | 0.23% | 0.26% | 0.18% | 0.19% | 0.34% |
| Capitalization / Revenue | 9.66 x | 8.7 x | 11.9 x | 12.1 x | 10.3 x |
| EV / Revenue | 9.66 x | 8.48 x | 11.9 x | 11.8 x | 9.96 x |
| EV / EBITDA | 21.9 x | 21.4 x | 29.5 x | 29.1 x | 24.3 x |
| EV / FCF | 125 x | 97.9 x | -94.1 x | 65.8 x | 38.6 x |
| FCF Yield | 0.8% | 1.02% | -1.06% | 1.52% | 2.59% |
| Price to Book | 9.54 x | 7.33 x | 12.8 x | 10.4 x | 7.37 x |
| Nbr of stocks (in thousands) | 1,01,966 | 1,02,071 | 1,02,516 | - | - |
| Reference price 2 | 438.2 | 391.3 | 802.9 | 802.9 | 802.9 |
| Announcement Date | 26/05/22 | 29/05/23 | 08/05/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 4,624 | 4,592 | 5,478 | 6,787 | 7,954 |
| EBITDA 1 | - | 2,037 | 1,820 | 2,209 | 2,763 | 3,265 |
| EBIT 1 | - | 1,510 | 1,203 | 1,639 | 2,088 | 2,523 |
| Operating Margin | - | 32.66% | 26.2% | 29.92% | 30.76% | 31.72% |
| Earnings before Tax (EBT) 1 | - | 1,474 | 1,135 | 1,587 | 2,025 | 2,514 |
| Net income 1 | 842.6 | 1,097 | 846.3 | 1,188 | 1,518 | 1,884 |
| Net margin | - | 23.72% | 18.43% | 21.69% | 22.36% | 23.69% |
| EPS 2 | 8.260 | 10.69 | 8.260 | 11.59 | 14.84 | 18.30 |
| Free Cash Flow 1 | - | 356.5 | 397.7 | -856.7 | 1,220 | 2,052 |
| FCF margin | - | 7.71% | 8.66% | -15.84% | 17.98% | 25.8% |
| FCF Conversion (EBITDA) | - | 17.5% | 21.85% | - | 44.16% | 62.85% |
| FCF Conversion (Net income) | - | 32.5% | 46.99% | - | 80.4% | 108.91% |
| Dividend per Share 2 | - | 1.000 | 1.000 | 1.420 | 1.500 | 2.733 |
| Announcement Date | 05/06/21 | 26/05/22 | 29/05/23 | 08/05/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 1,108 | 1,162 | 1,044 | 1,207 | 1,131 | 1,210 | 1,210 | 1,369 | 1,321 | 1,493 |
| EBITDA 1 | - | 478.3 | 478.6 | 398.9 | 487.4 | 442.9 | 491.1 | 481.2 | 553.5 | 520.2 | 608 |
| EBIT | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | 237.2 | - | - | - | - | - | - | - |
| Net income 1 | 277.1 | 252.9 | - | 174.5 | 233.3 | 163.6 | 274.9 | 263.8 | 311 | 277 | 308 |
| Net margin | - | 22.83% | - | 16.72% | 19.32% | 14.47% | 22.72% | 21.8% | 22.72% | 20.97% | 20.63% |
| EPS | 2.700 | 2.460 | - | 1.700 | 2.270 | 1.600 | - | - | - | - | 3.000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 08/11/21 | 04/02/22 | 26/05/22 | 09/08/22 | 10/11/22 | 13/02/23 | 29/05/23 | 09/08/23 | - | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 1,019 | 1,708 | 1,974 | 3,074 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 357 | 398 | -857 | 1,220 | 2,052 |
| ROE (net income / shareholders' equity) | - | 26.5% | 16.7% | 19.5% | 20.8% | 21.4% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 45.90 | 53.40 | 62.60 | 76.90 | 109.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 1,223 | 1,248 | 2,331 | 1,177 | 1,129 |
| Capex / Sales | - | 26.46% | 27.19% | 43.1% | 17.34% | 14.2% |
| Announcement Date | 05/06/21 | 26/05/22 | 29/05/23 | 08/05/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
802.9
INR
Average target price
750.6
INR
Spread / Average Target
-6.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.82% | 985M | |
| -16.58% | 8.49B | |
| +58.90% | 4.08B | |
| -39.78% | 2.42B | |
| -10.33% | 2.42B | |
| -8.91% | 2.33B | |
| -2.53% | 2.01B | |
| -19.90% | 1.53B | |
| -38.30% | 1.26B | |
| +2.19% | 1.07B |
- Stock Market
- Equities
- VIJAYA Stock
- Financials Vijaya Diagnostic Centre Limited
